Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S
A/S
Active
CVR 29428689
Smedeskovvej 38, 8464
Galten
Technical testing and analysis
· NACE 7120
Est. 2006
98 employees
Watchlist
Share
Denmark
/
Companies
/
Technical testing and analysis
/
EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
19M
37M
56M
75M
52M
2020
57M
2021
65M
2022
54M
2023
65M
2024
EBITDA
DKK millions
0M
6M
12M
17M
23M
15M
2020
17M
2021
15M
2022
7M
2023
20M
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
51.639
56.810
64.507
54.477
64.991
Staff expenses
-36.329
-39.500
-49.649
-47.589
-45.234
EBITDA
15.309
17.311
14.858
6.888
19.757
Depreciation & amort.
-2.125
-2.398
-2.217
-3.893
-5.070
EBIT
13.184
14.913
12.641
2.995
14.686
Net financials
-676
-82
-441
-1.390
-903
Profit before tax
12.508
14.831
12.200
1.605
13.784
Tax
2.751
3.276
2.688
358
3.041
Net profit
9.757
11.555
9.512
1.247
10.743
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
44.879
49.312
60.863
64.488
86.649
Equity
12.994
18.549
18.061
12.807
22.550
Long-term debt
9.326
9.278
16.278
30.446
3.498
Short-term debt
22.559
21.485
26.524
21.234
60.602
Total debt
31.885
30.763
42.802
51.680
64.099
Financial ratios
5-year trend
EBITDA margin
30.4%
This company
15.8%
Market median
+92% vs market
2020
2024
Equity ratio
26.0%
This company
38.2%
Market median
-32% vs market
2020
2024
Return on equity
47.6%
This company
18.4%
Market median
+159% vs market
2020
2024
Net profit margin
16.5%
This company
8.1%
Market median
+104% vs market
2020
2024
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
2020
2024
Debt / equity
2.84×
This company
0.62×
Market median
-358% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on EUROFINS BIOPHARMA PRODUCT TESTING DENMARK A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
